Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies
Xingping Han(Affiliated Hospital of Southwest Medical University), Qiang Liu(Sun Yat-sen University), Hossein Hosseinifard(Hamedan University of Medical Sciences), Lisha Yang(National Clinical Research Center for Digestive Diseases), Saber İmani(Zhejiang Shuren University), Gang Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaozhi Fu(Sichuan University), Shuya Liu(Universität Hamburg), Qinglian Wen(Affiliated Hospital of Southwest Medical University), Mazaher Maghsoudloo(Islamic Azad University Medical Branch of Tehran)
Cited by 53
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Multiorgan and Renal Tropism of SARS-CoV-2
|New England Journal of Medicine|2020|1.9k
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
|Annals of Oncology|2021|743
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|434
An Ultrasound Activated Vesicle of Janus Au‐MnO Nanoparticles for Promoted Tumor Penetration and Sono‐Chemodynamic Therapy of Orthotopic Liver Cancer
|Angewandte Chemie International Edition|2019|338